Status:
RECRUITING
99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors
Lead Sponsor:
Nanjing First Hospital, Nanjing Medical University
Conditions:
Head and Neck Tumor
Lung Cancer
Eligibility:
All Genders
18-75 years
Brief Summary
At present, radiopharmaceuticals targeting FAP have been developed for the diagnosis and treatment of various tumors. Considering the problems of fast tumor tissue clearance and short retention time i...
Eligibility Criteria
No eligibility criteria provided.
Key Trial Info
Start Date :
June 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06438705
Start Date
June 1 2024
End Date
May 31 2026
Last Update
March 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanjing First Hospital
Nanjing, Jiangsu, China, 210006